Maravai Lifesciences Holdings Inc Asset Turnover Ratio (MRVI), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Maravai Lifesciences Holdings Inc   (NASDAQ: MRVI)
 

Maravai Lifesciences Holdings Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Maravai Lifesciences Holdings Inc asset turnover ratio, the ability of Maravai Lifesciences Holdings Inc 's assets to generate revenue in the second quarter 2026, increased sequentially to 0.28 in the second quarter (Jun 30 2026), yet the ratio remained below the average, as MRVI's position remain challenging.

Within sector 62 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 1750, from total ranking in the first quarter 2026 at 2615.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MRVI Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change -32.69 % -25.69 % -23.57 % -33.56 % -37.87 %
Y / Y Revenue Change 8.53 % 40.24 % -11.2 % -37.65 % -35.43 %
Asset Turnover Ratio (TTM) 0.28 0.25 0.21 0.21 0.21
MRVI's Total Ranking # 1750 # 2615 # 2549 # 2496 # 2478
Seq. Asset Change -15.35 % -7.44 % -9.26 % -5.33 % -6.54 %
Seq. Revenue Change -21.7 % 31.17 % 23.2 % -14.22 % 1.17 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 63
Healthcare Sector # 203
Overall Market # 1750

Asset Turnover Ratio Statistics
High Average Low
9.25 6.96 4.87
(Mar 31 2022)   (Mar 31 2021)




MRVI Company Profile • Back to MRVI Efficiency Comparisons • Compare MRVI Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Travere Therapeutics Inc   0.95 $ 591.330  Millions$ 624.580  Millions
Vaso Corporation  0.94 $ 80.220  Millions$ 85.428  Millions
Alnylam Pharmaceuticals Inc   0.94 $ 4,804.182  Millions$ 5,126.577  Millions
Apyx Medical Corp  0.94 $ 58.105  Millions$ 62.076  Millions
Community Health Systems Inc   0.93 $ 11,983.000  Millions$ 12,950.000  Millions
Rosecliff Acquisition Corp I  0.91 $ 16.467  Millions$ 18.038  Millions
Embecta Corp   0.91 $ 1,019.700  Millions$ 1,119.100  Millions
Genedx Holdings Corp   0.91 $ 455.446  Millions$ 501.350  Millions
Exelixis Inc   0.91 $ 2,435.920  Millions$ 2,688.949  Millions
Pediatrix Medical Group Inc   0.90 $ 1,950.625  Millions$ 2,161.685  Millions
Organogenesis Holdings Inc   0.90 $ 457.454  Millions$ 508.749  Millions
Lakeland Industries Inc   0.90 $ 190.961  Millions$ 212.379  Millions
Si bone inc   0.89 $ 214.331  Millions$ 241.076  Millions
Fennec Pharmaceuticals Inc   0.89 $ 59.221  Millions$ 66.847  Millions
Premier Air Charter Holdings Inc   0.88 $ 31.562  Millions$ 35.785  Millions
Accuray Incorporated  0.88 $ 400.833  Millions$ 454.583  Millions
Teladoc Health Inc   0.88 $ 2,489.480  Millions$ 2,825.683  Millions
Trisalus Life Sciences Inc   0.88 $ 45.179  Millions$ 51.305  Millions
Ardelyx inc   0.87 $ 450.894  Millions$ 517.044  Millions
Atricure Inc   0.87 $ 567.747  Millions$ 652.563  Millions
Lensar Inc   0.87 $ 60.264  Millions$ 69.354  Millions
Encompass Health Corporation  0.86 $ 6,206.100  Millions$ 7,181.525  Millions
Regen Biopharma Inc   0.86 $ 0.237  Millions$ 0.274  Millions
Xeris Biopharma Holdings Inc   0.86 $ 335.414  Millions$ 389.409  Millions
Bioventus Inc   0.86 $ 581.106  Millions$ 677.259  Millions
Protalix Biotherapeutics inc   0.85 $ 80.619  Millions$ 94.321  Millions
Amneal Pharmaceuticals Inc   0.85 $ 3,117.474  Millions$ 3,648.680  Millions
Phathom Pharmaceuticals Inc   0.85 $ 239.663  Millions$ 282.908  Millions
Cytosorbents Corporation  0.85 $ 35.663  Millions$ 42.114  Millions
Vivos Therapeutics Inc   0.85 $ 21.135  Millions$ 24.996  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.